Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Senderowicz, AM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
      Histone acetylation and the cell-cycle in cancer

      FRONTIERS IN BIOSCIENCE
    2. Robey, RW; Medina-Perez, WY; Nishiyama, K; Lahusen, T; Miyake, K; Litman, T; Senderowicz, AM; Ross, DD; Bates, SE
      Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells

      CLINICAL CANCER RESEARCH
    3. Senderowicz, AM
      Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies

      LEUKEMIA
    4. Sausville, EA; Arbuck, SG; Messmann, R; Headlee, D; Bauer, KS; Lush, RM; Murgo, A; Figg, WD; Lahusen, T; Jaken, S; Jing, XX; Roberge, M; Fuse, E; Kuwabara, T; Senderowicz, AM
      Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

      JOURNAL OF CLINICAL ONCOLOGY
    5. Bachrich, T; Thalhammer, T; Jager, W; Haslmayer, P; Alihodzic, B; Bakos, S; Hitchman, E; Senderowicz, AM; Penner, E
      Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases

      HEPATOLOGY
    6. Messmann, RA; Vitetta, ES; Headlee, D; Senderowicz, AM; Figg, WD; Schindler, J; Michiel, DF; Creekmore, S; Steinberg, SM; Kohler, D; Jaffe, ES; Stetler-Stevenson, M; Chen, HC; Ghetie, V; Sausville, EA
      A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma

      CLINICAL CANCER RESEARCH
    7. Wilson, WH; Sorbara, L; Figg, WD; Mont, EK; Sausville, E; Warren, KE; Balis, FM; Bauer, K; Raffeld, M; Senderowicz, AM; Monks, A
      Modulation of clinical drug resistance in a B cell lymphoma patient by theprotein kinase inhibitor 7-hydroxystaurosporine: Presentation of a novel therapeutic paradigm

      CLINICAL CANCER RESEARCH
    8. Li, YW; Bhuiyan, M; Alhasan, S; Senderowicz, AM; Sarkar, FH
      Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol

      CLINICAL CANCER RESEARCH
    9. Li, YW; Chinni, SR; Senderowicz, AM; Sarkar, FH
      Induction of growth inhibition and apoptosis in prostate cancer cells by flavopiridol

      INTERNATIONAL JOURNAL OF ONCOLOGY
    10. Senderowicz, AM
      Small molecule modulators of cyclin-dependent kinases for cancer therapy

      ONCOGENE
    11. Chao, SH; Fujinaga, K; Marion, JE; Taube, R; Sausville, EA; Senderowicz, AM; Peterlin, BM; Price, DH
      Flavopiridol inhibits P-TEFb and blocks HIV-1 replication

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Leost, M; Schultz, C; Link, A; Wu, YZ; Biernat, J; Mandelkow, EM; Bibb, JA; Snyder, GL; Greengard, P; Zaharevitz, DW; Gussio, R; Senderowicz, AM; Sausville, EA; Kunick, C; Meijer, L
      Paullones are potent inhibitors of glycogen synthase kinase-3 beta and cyclin-dependent kinase 5/p25

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    13. Senderowicz, AM; Sausville, EA
      Preclinical and clinical development of cyclin-dependent kinase modulators

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    14. Senderowicz, AM; Sausville, EA
      Re: Preclinical and clinical development of cyclin-dependent kinase modulators - Response

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    15. Sausville, EA; Senderowicz, AM
      Chemical cyclin-dependent kinase inhibitors - Therapeutic implications

      SIGNALING NETWORKS AND CELL CYCLE CONTROL
    16. Lee, HR; Chang, TH; Tebalt, MJ; Senderowicz, AM; Szabo, E
      Induction of differentiation accompanies inhibition of Cdk2 in a non-smallcell lung cancer cell line

      INTERNATIONAL JOURNAL OF ONCOLOGY
    17. Senderowicz, AM
      Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials

      INVESTIGATIONAL NEW DRUGS
    18. Senderowicz, AM; Reid, R; Headlee, D; Abornathy, T; Horti, J; Lush, RM; Reed, E; Figg, WD; Sausville, EA
      A phase II trial of gallium nitrate in patients with androgen-metastatic prostate cancer

      UROLOGIA INTERNATIONALIS
    19. Schnier, JB; Kaur, G; Kaiser, A; Stinson, SF; Sausville, EA; Gardner, J; Nishi, K; Bradbury, EM; Senderowicz, AM
      Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein

      FEBS LETTERS
    20. Melillo, G; Sausville, EA; Cloud, K; Lahusen, T; Varesio, L; Senderowicz, AM
      Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic inductionof vascular endothelial growth factor expression in human monocytes

      CANCER RESEARCH
    21. Carlson, B; Lahusen, T; Singh, S; Loaiza-Perez, A; Worland, PJ; Pestell, R; Albanese, C; Sausville, EA; Senderowicz, AM
      Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol

      CANCER RESEARCH
    22. Zaharevitz, DW; Gussio, R; Leost, M; Senderowicz, AM; Lahusen, T; Kunick, C; Meijer, L; Sausville, EA
      Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases

      CANCER RESEARCH
    23. SAUSVILLE EA; HEADLEE D; STINSON SF; LUSH RM; FIGG WD; ARBUCK SG; SENDEROWICZ AM
      CYCLIN-DEPENDENT KINASES - TARGETS FOR NOVEL THERAPEUTIC APPROACHES

      Annals of oncology
    24. SENDEROWICZ AM; HEADLEE D; LUSH R; ARBUCK S; BAUER K; FIGG WD; MURGO A; INOUE K; KOBASHI S; KUWABARA T; SAUSVILLE EA
      PHASE-I TRIAL OF INFUSIONAL UCN-01, A NOVEL PROTEIN-KINASE INHIBITOR,IN PATIENTS WITH REFRACTORY NEOPLASMS

      Annals of oncology
    25. SENDEROWICZ AM; HEADLEE D; STINSON SF; LUSH RM; KALIL N; VILLALBA L; HILL K; STEINBERG SM; FIGG WD; TOMPKINS A; ARBUCK SG; SAUSVILLE EA
      PHASE-I TRIAL OF CONTINUOUS-INFUSION FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, IN PATIENTS WITH REFRACTORY NEOPLASMS

      Journal of clinical oncology
    26. SAUSVILLE EA; LUSH RD; HEADLEE D; SMITH AC; FIGG WD; ARBUCK SG; SENDEROWICZ AM; FUSE E; TANII H; KUWABARA T; KOBAYASHI S
      CLINICAL-PHARMACOLOGY OF UCN-01 - INITIAL OBSERVATIONS AND COMPARISONTO PRECLINICAL MODELS

      Cancer chemotherapy and pharmacology
    27. FOGT F; VORTMEYER AO; SENDEROWICZ AM
      SODIUM POLYSTYRENE SULFONATE DAMAGE

      The American journal of surgical pathology
    28. JAGER W; ZEMBSCH B; WOLSCHANN P; PITTENAUER E; SENDEROWICZ AM; SAUSVILLE EA; SEDLACEK HH; GRAF J; THALHAMMER T
      METABOLISM OF THE ANTICANCER DRUG FLAVOPIRIDOL, A NEW INHIBITOR OF CYCLIN-DEPENDENT KINASES, IN RAT-LIVER

      Life sciences
    29. PATEL V; SENDEROWICZ AM; PINTO D; IGISHI T; RAFFELD M; QUINTANILLAMARTINEZ L; ENSLEY JF; SAUSVILLE EA; GUTKIND JS
      FLAVOPIRIDOL, A NOVEL CYCLIN-DEPENDENT KINASE INHIBITOR, SUPPRESSES THE GROWTH OF HEAD AND NECK SQUAMOUS-CELL CARCINOMAS BY INDUCING APOPTOSIS

      The Journal of clinical investigation
    30. Yu, LJ; Orlandi, L; Wang, P; Orr, MS; Senderowicz, AM; Sausville, EA; Silvestrini, R; Watanabe, N; Piwnica-Worms, H; O'Connor, PM
      UCN-01 abrogates G(2) arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    31. FUSE E; TANII H; KURATA N; KOBAYASHI H; SHIMADA Y; TAMURA T; SASAKI Y; TANIGAWARA Y; LUSH RD; HEADLEE D; FIGG WD; ARBUCK SG; SENDEROWICZ AM; SAUSVILLE EA; AKINAGA S; KUWAHARA A; KOBASASHI S
      UNPREDICTED CLINICAL-PHARMACOLOGY OF UCN-01 CAUSED BY SPECIFIC BINDING TO HUMAN ALPHA(1)-ACID GLYCOPROTEIN

      Cancer research
    32. PARKER BW; KAUR G; NIEVESNEIRA W; TAIMI M; KOHLHAGEN G; SHIMIZU T; LOSIEWICZ MD; POMMIER Y; SAUSVILLE EA; SENDEROWICZ AM
      EARLY INDUCTION OF APOPTOSIS IN HEMATOPOIETIC-CELL LINES AFTER EXPOSURE TO FLAVOPIRIDOL

      Blood
    33. DAWSON NA; FIGG WD; COOPER MR; SARTOR O; BERGAN RC; SENDEROWICZ AM; STEINBERG SM; TOMPKINS A; WEINBERGER B; SAUSVILLE EA; REED E; MYERS CE
      PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER

      Journal of clinical oncology
    34. KATZ RL; QUEZADO M; SENDEROWICZ AM; VILLALBA L; LASKIN WB; TSOKOS M
      AN INTRAABDOMINAL SMALL ROUND-CELL NEOPLASM WITH FEATURES OF PRIMITIVE NEUROECTODERMAL AND DESMOPLASTIC ROUND-CELL TUMOR AND A EWS FLI-1 FUSION TRANSCRIPT/

      Human pathology
    35. SHENFELD M; SENDEROWICZ AM; SAUSVILLE EA; BARRETT KE
      A NOVEL CHEMOTHERAPEUTIC AGENT, FLAVOPIRIDOL, MODULATES INTESTINAL EPITHELIAL CHLORIDE SECRETION

      Gastroenterology
    36. LUSH RM; STINSON S; SENDEROWICZ AM; HILL K; FEUER J; HEADLEE D; FIGG W; SAUSVILLE E
      FLAVOPIRIDOL (NSC649890) PHARMACOKINETICS SUGGEST ENTEROHEPATIC CIRCULATION

      Clinical pharmacology and therapeutics
    37. SENDEROWICZ AM; VITETTA E; HEADLEE D; GHETIE V; UHR JW; FIGG WD; LUSH RM; STETLERSTEVENSON M; KERSHAW G; KINGMA DW; JAFFE ES; SAUSVILLE EA
      COMPLETE SUSTAINED RESPONSE OF A REFRACTORY, POSTTRANSPLANTATION, LARGE B-CELL LYMPHOMA TO AN ANTI-CD22 IMMUNOTOXIN

      Annals of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 11:05:36